One new national invention patent of probiotics authorized

Good news! Zhongke-Jiayi Bioengineering Company has recently been granted one new probiotics invention patent by the State Intellectual Property Office: Lactococcus lactis JYLL-60 and its application in the preparation of immunity enhancing products. This is the 17th invention patent strains owned by our company.

Although the immune cells in human body are born, but the function it plays in a lifetime is like a parabola, it starts to go downhill after 25 years old; after 30 years old, the decline is more obvious; around 40 years old, the immune ability is only 1/2 of the peak period; and at 70 years old, the immune function declines to almost 1/10.

It is very crucial to improve the autoimmunity. For middle-aged, elderly and frail patients, the invention provides Lactococcus lactis JYLL-60 with high survival rate in the gastrointestinal tract and intestinal colonization rate, and has a positive effect on the proliferation of spleen lymphocytes and the survival of NK cells, which can be used for balancing immunity, delaying aging, improving subhealth and warding off diseases.

Innovation is the first driving force to lead the development. The technical team of Zhongke-Jiayi always puts technological innovation in an important position, and continues to make efforts in the field of functional probiotics to achieve new breakthroughs and new achievements.

The team has made outstanding contributions in the discipline field with dedicated research and continuous innovation, and has been highly recognized by the industry and customers. In the next step, the compsny will continue to increase the investment in R&D probiotics, accelerate the pace of innovation, further enhance the technical innovation capability and promote the technological development of China's probiotics industry.